“The House bill is badly flawed and is an invitation to infringement.”
— Stephen Ubl of AdvaMed, commenting on current progress toward U.S. patent reform, “Imaging, patent reform among AdvaMed 2008 policy concerns,” pp. 1, 9.
To read more on related topics, click on one of the words below.